Evidence map›Paper›PMID 33918447›Full record

ArticleViruses2021

Evaluation of an Automated High-Throughput Liquid-Based RNA Extraction Platform on Pooled Nasopharyngeal or Saliva Specimens for SARS-CoV-2 RT-PCR.

Allen Wing-Ho Chu, Cyril Chik-Yan Yip, Wan-Mui Chan, Anthony Chin-Ki Ng, Dream Lok-Sze Chan, Ryan Ho-Ping Siu, Cheuk Yiu Tenny Chung, Jessica Pui-Ling Ng, Harsha Kittur, Garrett Lee Mosley and 3 more

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in Viruses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Allen Wing-Ho ChuState Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Cyril Chik-Yan YipDepartment of Microbiology, Queen Mary Hospital, Pok Fu Lam, Hong Kong.
Wan-Mui ChanState Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Anthony Chin-Ki NgState Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Dream Lok-Sze ChanPHASE Scientific International Limited, Kowloon, Hong Kong.
Ryan Ho-Ping SiuPHASE Scientific International Limited, Kowloon, Hong Kong.
Cheuk Yiu Tenny ChungPHASE Scientific International Limited, Kowloon, Hong Kong.
Jessica Pui-Ling NgPHASE Scientific International Limited, Kowloon, Hong Kong.
Harsha KitturPHASE Scientific International Limited, Kowloon, Hong Kong.
Garrett Lee MosleyPHASE Scientific International Limited, Kowloon, Hong Kong.
Rosana Wing-Shan PoonDepartment of Microbiology, Queen Mary Hospital, Pok Fu Lam, Hong Kong.
Ricky Yin-To ChiuPHASE Scientific International Limited, Kowloon, Hong Kong.
Kelvin Kai-Wang ToState Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Queen Mary Hospital · CNUniversity of Hong Kong · HK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SARS-CoV-2 RT-PCR with pooled specimens has been implemented during the COVID-19 pandemic as a cost- and manpower-saving strategy for large-scale testing. However, there is a paucity of data on the efficiency of different nucleic acid extraction platforms on pooled specimens. This study compared a novel automated high-throughput liquid-based RNA extraction (LRE) platform (PHASIFY™) with a widely used magnetic bead-based total nucleic acid extraction (MBTE) platform (NucliSENS

Indexed as

COVID-19 Nucleic Acid TestingCOVID-19HumansMass ScreeningNasopharynxRNA, ViralSalivaSARS-CoV-2Specimen HandlingRNA, ViralCOVID-19diagnosticsliquid-based nucleic acid extractionmass screeningnasopharyngeal swabpooled specimensRT-PCRsalivaSARS-CoV-2

Identifiers

PMID33918447
PMCPMC8067048
OpenAlexW3151617345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.